ReviewChemistry & biodiversity2026
Phytochemistry, Pharmacological Potential, and Future Prospects of Abietane-Type Diterpenoids From Salvia rosmarinus.
Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Salvia rosmarinus, formerly known as Rosmarinus officinalis, is a medicinal plant known as one of the sources of abietane-type diterpenoids. The largest family of chemical constituents from the Salvia genus is abietanes and rearranged abietanes. Since 1976, 365 of the 545 known diterpenoids have been recognized as abietane diterpenoids. Carnosic acid, carnosol, rosmanol, epirosmanol, and their derivatives are among the bioactive abietanes that have gained much attention because of the wide spectrum of pharmacological activities. This review presents information on the distribution, isolation, biosynthesis, structural variation, degradation, semi-synthetic strategies, pharmacokinetics, and bioactivities of abietane-type diterpenoids from S. rosmarinus. Recent developments in eco-friendly extraction techniques, namely, supercritical fluid extraction, microwave-assisted extraction, ultrasound-assisted extraction, and pressurized liquid extraction, are also described in this review. The biosynthetic pathway from geranylgeranyl diphosphate to main diterpenoids, such as carnosic acid and carnosol, is also presented. Moreover, newly isolated compounds, structure-activity relationships, and antioxidant, antimicrobial, anti-inflammatory, neuroprotective, and anticancer activities are included. Moreover, the pharmacokinetics of abietane diterpenoids isolated from S. rosmarinus and their medicinal applications are also covered in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.